Kumar S - Search Results

1

Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis.

Petit C, Lacas B, Pignon JP, Le QT, Grégoire V, Grau C, Hackshaw A, Zackrisson B, Parmar MKB, Lee JW, Ghi MG, Sanguineti G, Temam S, Cheugoua-Zanetsie M, O'Sullivan B, Posner MR, Vokes EE, Cruz Hernandez JJ, Szutkowski Z, Lartigau E, Budach V, Suwiński R, Poulsen M, Kumar S, Ghosh Laskar S, Mazeron JJ, Jeremic B, Simes J, Zhong LP, Overgaard J, Fortpied C, Torres-Saavedra P, Bourhis J, Aupérin A, Blanchard P; MACH-NC and MARCH Collaborative Groups. Petit C, et al. Among authors: kumar s. Lancet Oncol. 2021 May;22(5):727-736. doi: 10.1016/S1470-2045(21)00076-0. Epub 2021 Apr 13. Lancet Oncol. 2021. PMID: 33862002

2

Concomitant boost radiotherapy with concurrent weekly cisplatin in advanced head and neck cancers: a phase II trial.

Kumar S, Pandey M, Lal P, Rastogi N, Maria Das KJ, Dimri K. Kumar S, et al. Radiother Oncol. 2005 May;75(2):186-92. doi: 10.1016/j.radonc.2004.12.004. Epub 2004 Dec 23. Radiother Oncol. 2005. PMID: 16086908 Clinical Trial.

3

Changes in salivary flow rates in head and neck cancer after chemoradiotherapy.

Lal P, Bajpai R, Khurana R, Das KJ, Kumar P, Tiwari A, Gupta N, Kumar S. Lal P, et al. Among authors: kumar s, kumar p. J Cancer Res Ther. 2010 Oct-Dec;6(4):458-62. doi: 10.4103/0973-1482.77105. J Cancer Res Ther. 2010. PMID: 21358080 Free article.

4

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group.

Lacas B, Carmel A, Landais C, Wong SJ, Licitra L, Tobias JS, Burtness B, Ghi MG, Cohen EEW, Grau C, Wolf G, Hitt R, Corvò R, Budach V, Kumar S, Laskar SG, Mazeron JJ, Zhong LP, Dobrowsky W, Ghadjar P, Fallai C, Zakotnik B, Sharma A, Bensadoun RJ, Ruo Redda MG, Racadot S, Fountzilas G, Brizel D, Rovea P, Argiris A, Nagy ZT, Lee JW, Fortpied C, Harris J, Bourhis J, Aupérin A, Blanchard P, Pignon JP; MACH-NC Collaborative Group. Lacas B, et al. Among authors: kumar s. Radiother Oncol. 2021 Mar;156:281-293. doi: 10.1016/j.radonc.2021.01.013. Epub 2021 Jan 27. Radiother Oncol. 2021. PMID: 33515668 Free PMC article.

5

A Pilot Study of Perioperative Cisplatin-Capecitabine Chemotherapy With Preoperative Chemoradiation for Resectable Gastric Cancers.

Misra S, Yeshala SK, Singh S, Singh RK, Maria Das KJ, Kumar S, Kumar S. Misra S, et al. Among authors: kumar s. Am J Clin Oncol. 2021 Sep 1;44(9):475-481. doi: 10.1097/COC.0000000000000844. Am J Clin Oncol. 2021. PMID: 34183522 Clinical Trial.

6

A randomised trial of radiotherapy compared with cisplatin chemo-radiotherapy in patients with unresectable squamous cell cancer of the esophagus.

Kumar S, Dimri K, Khurana R, Rastogi N, Das KJ, Lal P. Kumar S, et al. Radiother Oncol. 2007 May;83(2):139-47. doi: 10.1016/j.radonc.2007.03.013. Epub 2007 Apr 18. Radiother Oncol. 2007. PMID: 17445928 Clinical Trial.

7

Role of survivin gene promoter polymorphism (-31G>C) in susceptibility and survival of esophageal cancer in northern India.

Upadhyay R, Khurana R, Kumar S, Ghoshal UC, Mittal B. Upadhyay R, et al. Among authors: kumar s. Ann Surg Oncol. 2011 Mar;18(3):880-7. doi: 10.1245/s10434-010-1371-y. Epub 2010 Oct 19. Ann Surg Oncol. 2011. PMID: 20957442

8

Modification of risk, but not survival of esophageal cancer patients by esophageal cancer-related gene 1 Arg290Gln polymorphism: a case-control study and meta-analysis.

Umar M, Upadhyay R, Kumar S, Ghoshal UC, Mittal B. Umar M, et al. Among authors: kumar s. J Gastroenterol Hepatol. 2013 Nov;28(11):1717-24. doi: 10.1111/jgh.12335. J Gastroenterol Hepatol. 2013. PMID: 23869757

9

Ipsilateral lung dose volume parameters predict radiation pneumonitis in addition to classical dose volume parameters in locally advanced NSCLC treated with combined modality therapy.

Agrawal S, Kumar S, Lawrence A, Das MK, Kumar S. Agrawal S, et al. Among authors: kumar s. South Asian J Cancer. 2014 Jan;3(1):13-5. doi: 10.4103/2278-330X.126503. South Asian J Cancer. 2014. PMID: 24665439 Free PMC article.

10

Long term results of comparison of concurrent low-dose daily cisplatin versus the standard weekly cisplatin with six fractions per week radiotherapy in locally advanced head neck cancer.

Gupta PK, Lal P, Bajpai R, Goel A, Yadav R, Verma M, Kumar S. Gupta PK, et al. Among authors: kumar s. South Asian J Cancer. 2016 Apr-Jun;5(2):80-4. doi: 10.4103/2278-330X.181647. South Asian J Cancer. 2016. PMID: 27275456 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

30,189 results

Search Page